OptimizeRx OPRX Debt Issuance Cost Amortization
Debt Issuance Cost Amortization at other companies
Other financials
Where this comes from
Reported directly by OptimizeRx in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.
The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about OptimizeRx's debt issuance cost amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OptimizeRx's debt issuance cost amortization?
- OptimizeRx (OPRX) reported debt issuance cost amortization of $358K in Q1 2026.
- How has OptimizeRx's debt issuance cost amortization changed year-over-year?
- OptimizeRx's debt issuance cost amortization increased by 105.7% year-over-year, from $174K to $358K.
- What is the long-term trend for OptimizeRx's debt issuance cost amortization?
- Over 2 years (2023 to 2025), OptimizeRx's debt issuance cost amortization has grown at a 129.4% compound annual growth rate (CAGR), from $211K to $1.11M.
- What does debt issuance cost amortization mean?
- Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).